Trial Profile
A Phase I, Partially Randomized, Open Label, Two-way, Two Period Cross-over Study to Investigate the Pharmacokinetic Interaction Between Etravirine or Darunavir/Rtv and Artemether/Lumefantrine at Steady-state in Healthy HIV-negative Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Artemether/lumefantrine (Primary) ; Darunavir (Primary) ; Etravirine (Primary) ; Ritonavir (Primary)
- Indications HIV infections; Malaria
- Focus Pharmacogenomic; Pharmacokinetics; Therapeutic Use
- Acronyms DDI Coartem
- 19 Jun 2013 New trial record